<a href="https://laohu8.com/S/PALI">Palisade Bio Inc.</a> Introduces Phantom Equity Plan, Grants Phantom Units to Key Executives and Directors
Palisade Bio Inc. has introduced a new compensation plan involving the issuance of cash-settled phantom units to its employees, directors, and consultants. Approved by the Board of Directors on September 4, 2025, the Phantom Unit Plan allows for up to 10 million phantom units to be granted, each linked in value to the company's common stock. Under this plan, key executives, including CEO J.D. Finley, received 323,400 phantom units, while Chief Medical Officer Mitchell Jones and Senior Vice President of Finance Ryker Willie were awarded 289,000 and 137,600 units, respectively. The Board Chair and other independent directors also received allocations, solidifying the company's commitment to aligning its leadership's interests with long-term corporate performance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-012687), on September 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.